New research highlights the significance of dosage in haploinsufficiency related to osteogenesis imperfecta. This study provides insights that could influence future therapeutic strategies for this brittle bone disease.

A recent study published in PubMed highlights the occurrence of atypical femoral fractures in adults with classical osteogenesis imperfecta. This research underscores the need for increased awareness and monitoring of fracture risks in this patient population.

A 12-month longitudinal study published in PubMed evaluates the effectiveness of etoricoxib on bone microarchitecture in patients with osteogenesis imperfecta. The study utilized high-resolution peripheral quantitative computed tomography (HR-pQCT) to assess changes in bone structure.

Quinnipiac University students organized a Rare Disease Day event to promote advocacy and education for rare diseases, emphasizing the importance of preparing future healthcare professionals. The event highlighted personal stories, including the impact of the OI Foundation on families affected by osteogenesis imperfecta.

Quinnipiac University will host 'Rare Disease Day 2026' on February 20, 2026, focusing on Osteogenesis Imperfecta and the need for more research and breakthroughs. The event aims to unite patients, scientists, and advocates to drive progress for rare disease families.